Kyrocep-CV

Each film coated tablet contains:
Cefpodoxime Proxetil equivalent to Cefpodoxime 200 mg
Potassium Clavulanate Diluted equivalent to Clavulanic Acid 125 mg.

Genitourinary Tract Infection, Upper and Lower Respiratory Tract Infections (acute bronchitis, community-acquired pneumonia), sinusitis, tonsillitis, and skin/soft tissue infections.

One tablet twice daily after food or as directed by the physician.

Notice: Dosage schedules should be tailored according to clinical assessment and physician direction.

Store protected from light and moisture at a temperature not exceeding 25°C.

Kyrocep-CV pairs a third-generation cephalosporin with a beta-lactamase inhibitor. Potassium Clavulanate overcomes bacterial enzymatic resistance, restoring full therapeutic power against beta-lactamase producing pathogens.